MedPath

Analysis of Defocus Curve of Pre-Presbyopic and Emerging Presbyopic Patients

Completed
Conditions
Presbyopia
Registration Number
NCT04474782
Lead Sponsor
Vance Thompson Vision
Brief Summary

Educating patients on visual performance with presbyopic correcting intraocular lenses is crucial. Understanding the defocus curve of pre-presbyopic and emerging presbyopic crystalline lens will provide eye care provides useful information to better educate patients on visual performance expectations after cataract surgery with a presbyopic correcting intraocular lens. Our objective will be to assess the subjective range of clear vision of a pre-presbyopic and emerging presbyopic patient population utilizing a defocus curve. A comparison of the pre-presbyopic and emerging presbyopic defocus curve to all FDA-approved presbyopic intraocular lenses will be discussed in the manuscript.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
45
Inclusion Criteria
  1. Able and willing to provide written informed consent on the IRB approved Informed Consent Form
  2. 37-48 years of age
  3. Phakic
Exclusion Criteria
  1. Previous cataract surgery
  2. Any pathology for which, in the investigator's judgement, could reduce the subjects BCVA
  3. Subjects that are unable to obtain 20/20 BCVA (i.e. amblyopia, etc.)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in LogMar visual acuity during vision testing on ETDRS with loose lensesScreening/enrollment visit
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Vance Thompson Vision

🇺🇸

Sioux Falls, South Dakota, United States

© Copyright 2025. All Rights Reserved by MedPath